Official website of the National Medical Insurance Bureau showed that spleen aminopeptide was kicked out of medical insurance because of the pressure of medical insurance fund and cost control. Spleen aminopeptide is a biological product, which has many uses in medicine and can improve immunity. In China, the proportion of medical insurance reimbursement is 50% to 90%.